Skip to main content
Premium Trial:

Request an Annual Quote

Arcxis, Roche Collaborate on Molecular Diagnostics Sample Prep

NEW YORK (GenomeWeb News) – Arcxis Biotechnologies said today that it will collaborate with Roche Molecular Systems, a business area of Roche Diagnostics, on sample-preparation technology for molecular diagnostics.
 
Under the collaboration, Arcxis will use its proprietary total RNA and genomic DNA isolation and concentration technology with PCR and RT-PCR-based diagnostic tests. The company expects that its methods for preparing blood and tissue will produce “significant performance benefits” for PCR-based tests.
 
Arcxis said the partnership offers an opportunity to apply its technologies to infectious disease and cancer detection tests.
 
“Many companies, large and small, have struggled to purify nucleic acids for molecular diagnostic tests. We believe that the application of our technology will extend the dynamic range of assays,” Jay West, Arcxis’ chief technology officer, said in a statement.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.